Which selective serotonin reuptake inhibitors have the shortest elimination half-lives?

SSRIs with the Shortest Half-Lives

Paroxetine, fluvoxamine, sertraline, and citalopram have the shortest elimination half-lives among SSRIs, ranging from approximately 21 to 36 hours, with paroxetine having the shortest at around 21 hours. 1

Pharmacokinetic Overview

The SSRIs demonstrate substantial differences in their elimination half-lives, which has important clinical implications:

Shortest Half-Life SSRIs (approximately 1 day):

• Paroxetine: ~21 hours 1
• Fluvoxamine: ~15-26 hours 2
• Sertraline: ~26 hours 2
• Citalopram: ~36 hours 1

Longest Half-Life SSRI:

• Fluoxetine: 2-4 days (with its active metabolite norfluoxetine having a half-life of 7-15 days) 1, 3

Clinical Implications of Short Half-Lives

The shorter half-lives of paroxetine, fluvoxamine, and sertraline make these agents more prone to discontinuation syndrome 4. This is particularly notable with paroxetine, which has been most strongly associated with withdrawal symptoms including dizziness, fatigue, sensory disturbances, and anxiety following missed doses or abrupt discontinuation 4.

Dosing Considerations

The shorter half-life SSRIs require more frequent monitoring during dose adjustments. Guidelines recommend dose titration at approximately 1- to 2-week intervals for shorter half-life SSRIs (sertraline, citalopram) compared to 3- to 4-week intervals for longer half-life SSRIs like fluoxetine 4.

In pediatric populations, some shorter half-life SSRIs may require twice-daily dosing:

• Sertraline at low doses may require twice-daily dosing in youth 4
• Fluvoxamine at any dose may require twice-daily dosing in youth 4

Common Pitfalls

The primary clinical caveat with short half-life SSRIs is the increased risk of discontinuation syndrome if doses are missed or therapy is abruptly stopped. Patients on paroxetine, fluvoxamine, or sertraline should be counseled about the importance of medication adherence and the need for gradual tapering when discontinuing treatment. The discontinuation syndrome can manifest with dizziness, paresthesias, anxiety, irritability, and flu-like symptoms 4.

In contrast, fluoxetine's extended half-life provides a built-in tapering effect and requires a 5-week washout period before initiating medications that interact with serotonin function (such as MAOIs) 5.